Crossmark

Prediction of pathological response and lymph node metastasis after neoadjuvant therapy in rectal cancer through tumor and mesorectal MRI radiomic features

Crossref DOI link: https://doi.org/10.1038/s41598-024-72916-9

Published Online: 2024-09-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qin, Siyuan

Liu, Ke

Chen, Yongye

Zhou, Yan

Zhao, Weili

Yan, Ruixin

Xin, Peijin

Zhu, Yupeng

Wang, Hao

Lang, Ning
Funding

Funding for this research was provided by:

Beijing United Imaging IntelligenceTechnology Research Institute Joint Research and Development Platform Foundation for Institutions and Enterprises (H79462-07)

National Natural Science Foundation of China (81971578)
License Information

Text and Data Mining valid from 2024-09-20

Version of Record valid from 2024-09-20
More Information

Article History

Received: 8 December 2023

Accepted: 11 September 2024

First Online: 20 September 2024

Declarations

:

: The authors declare no competing interests.

: This study obtained approval from the Institutional Review Board of Peking University Third Hospital (Ethics approval No.IRB00006761-M2022474). We confirmed that all research was performed in accordance with relevant guidelines and regulations, and due to its retrospective nature, the need for obtaining written informed consent was waived.

: Patient informed consent was waived by the Institutional Review Board of Peking University Third Hospital.

Document is current

Any future updates will be listed below